Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-18

Clinical Trial Update: Study to Evaluate SPI-1005 in Adults With Meniere's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for SPI-1005 in adults with Meniere's disease reporting completion of Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPI-1005

Snippet

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Meniere's Disease | Phase 1, Phase 2 | Status: COMPLETED